Please login to the form below

Not currently logged in
Email:
Password:

Rare Diseases and Orphan Drugs


Rare Diseases and Orphan Drugs

This category relates to the marketing of an orphan drug (for rare diseases or disorders), at any phase of the product life cycle. Entrants will need to demonstrate a thorough understanding of the specific environment and show appropriate marketing approach to drive the business forward.

Work conducted during the 18-month period between July 2010 and December 2011 will be eligible.


Judging criteria:

  • Recognition of the specific health environment
  • Evidence that the drug eas built upon customer insight
  • Explanation of positioning and evidence of effective brand building
  • Market access strategy & execution
  • Effective integration of tailored marketing tools and activities
  • Evidence of changed behaviours and enhanced health outcomes



Sponsors

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Genesis Research

Genesis Research is an international HEOR and RWE research organization. A leader in evidence strategy, generation and communication, the company...

Latest intelligence

What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...